Invited Video Presentations

Hover over speaker photo to view profile

Invited video presentations are imbedded within various Free Paper Oral presentation sessions.  The subject of the invited video presentation is aligned with the session of similar topic matter. The programme for invited video presentations is listed below with individual video presentations detailed within each relevant session of the programme.

Thursday, March 31, 2022 - 1300 - 1330hrs

Thursday, March 31, 2022

8:00 - 9:30
Daniel Cherqui MD; France
Enhanced Minimally-Invasive Liver Surgery Utilizing ICG


Free Papers 1: Liver 1
Daniel Cherqui Photo.jpg
Daniel Cherqui MD

Prof. Daniel Cherqui is currently Professor of Surgery at Université Paris-Sud and Surgical Director of Liver Transplantation at Paul Brousse Hospital in Villejuif-Paris France, home of the largest liver transplantation program in France. He is an internationally renowned expert with a vast personal experience in all aspects of liver transplantation and HPB surgery. He has published extensively and served as Associate Editor for the “Journal of Hepatology” 2014-2019. He is considered one of the pioneers of laparoscopic liver surgery and is the Founding President of the “International Laparoscopic Liver Society”.

 

Education:

- Medical school and Residency: University of Paris

- Fellowships: 1986 Prof. Henri Bismuth’s Unit – University of Paris and 1987 Prof Christoph Broelsch’s Unit - University of Chicago

 

Positions held

- Chief of Liver Transplantation and HPB Surgery: Henri Mondor University Hospital, Créteil-Paris 1988-2005

- Chairman of General Surgery: Henri Mondor University Hospital, Créteil-Paris 2005-2010

- Chief of HPB Surgery and Liver Transplantation: Weill Cornell Medical Center in New York, NY USA, 2010-2013

- Surgical Director of Liver Transplantation: Paul Brousse University Hospital, 2013

14:00 - 15:00
John Martinie MD; USA
Robotic Surgery



Free Papers 2: Pancreas 1
John Martinie - Photo.jpg
John Martinie MD

Dr. John Martinie currently holds the position of Professor of Surgery, Division of HPB Surgery at Carolinas Medical Center, a 1000-bed academic teaching hospital in Charlotte, North Carolina. He completed his general surgery training at Brown University and a fellowship in Transplantation and HPB surgery at McGill University and the Royal Victoria Hospital, in Montreal, Quebec. He performed his first robotic procedures in 2006, including distal pancreatectomies and hepaticojejunostomies. He was recruited to Charlotte in 2007 with the goal of building one of the pre-eminent HPB Surgical Fellowships in North America.

He now has over 16 years’ experience in robotic liver, pancreas, and biliary procedures, over 1200 cases, and one of the largest single-surgeon experiences in the world. He has numerous publications, book chapters, and videos, many of which are primarily concerned with robotic HPB surgery.

Most recently, Dr. Martinie has begun a new, one-year robotic HPB fellowship designed specifically for surgeons who have already completed a formalized HPB or Surgical Oncology fellowship, with the aim of expanding the field of experienced surgeons outside of North America who perform advanced robotic HPB procedures.

15:30 - 16:30
Philippe Compagnon MD; Switzerland
Split Liver Retrieval and Transplantation

Free Papers 7: Transplant 2
Philippe Compagnon - Photo.jpeg
Philippe Compagnon MD, PhD

Philippe Compagnon, MD, PhD, did his medical school at the University Claude Bernard in Lyon (France) and his surgical residency in Strasbourg (France). During his surgical fellowship (University Hospital - Rennes, 2002-2006, France) he acquired a solid experience in hepato-biliary surgery and liver transplantation. After a master and a 2 years research fellowship in the organ preservation laboratory of the University of Wisconsin (Madison – USA), he obtained a PhD degree in 2006. He worked for 6 years as a senior HPB and transplant surgeon at the University Hospital of Rennes before joining the Assistance Publique - Hôpitaux de Paris (APHP, University Hospital Mondor, France) in 2012 where he has been promoted to the title of professor of surgery (April 2015). In December 2017, he moved to the Geneva University Hospitals (Switzerland). His clinical work is divided into 2 complementary areas: liver transplantation and hepato-biliary surgery. He has an academic activity based on teaching and  - clinical and experimental - research, focusing on the way to improve the tolerance of the liver graft to preservation. He has an extensive experience in machine perfusion of solid organs. His research activity has led so far to 124 publications in international journals.

Thursday, March 31, 2022 - 1300 - 1330hrs

Thursday, March 31, 2022 - 1300 - 1330hrs

Yuman Fong MD; USA
KN01 - Palliative Liver Resection
 
KN01 - Y Fong - Photo.jpg
Yuman Fong MD

Dr. Yuman Fong is a graduate of Brown University (BA, Medieval Literature, 1981) and Cornell University Medical College (MD, 1984). He is the Sangiacomo Chair and Chairman of the Department of Surgery at the City of Hope Medical Center.

Dr. Fong is best known clinically for his extensive work in the field of liver and pancreatic surgery––especially for pioneering many laparoscopic, robotic and ablative therapies for these cancers. He has assisted in the design and deployment of many novel surgical tools.

Dr. Fong has also been active in biologic bench investigation.  His early research was in immune activation during cancer or infection.  He was part of the group that discovered tumor necrosis factor and helped established the field of innate immunity. His laboratory focus over the last 15 years has been in the field of gene therapy, designing and studying the use of genetically modified viruses for the killing of cancer. His group was the first to administer recombinant viruses into the blood stream of man as a cancer treatment. His leadership in this field on the national level has included serving as the Chair of the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health.

He has co-authored over 700 peer reviewed articles and 12 text books. He has served on the editorial boards of 14 journals, and is currently Editor-in-Chief of Molecular Therapy Oncolytics (Cell Press).

Julie Heimbach MD; USA
KN02 - Contemporary Management of Hilar Cholangiocarcinoma
KN02 - J Heimbach - Photo.jpg
Julie Heimbach MD

Julie Heimbach is a Professor of Surgery and the Chair of Division of Transplantation at the Mayo Clinic College of Medicine in Rochester, MN.  She has dedicated a significant amount of time to UNOS, having served on numerous committees as well as the Board of Directors, and most recently, as the chair of the liver-Intestine committee.   Dr. Heimbach also recently served on the ASTS council and currently serves as an Associate Editor both for the American Journal of Transplantation, and for the Journal of Hepatology.  Her clinical and research interests include liver transplantation for hepatobiliary malignancies, living donor transplantation, and obesity in liver transplantation.

Andrea Schlegel MD; Italy/Switzerland
KN03 - An Ideal Liver Graft
Machine Perfusion
IHPBA_2022_Logo_72dpi.png
Andrea Schlegel MD

Dr. Yuman Fong is a graduate of Brown University (BA, Medieval Literature, 1981) and Cornell University Medical College (MD, 1984). He is the Sangiacomo Chair and Chairman of the Department of Surgery at the City of Hope Medical Center.

Dr. Fong is best known clinically for his extensive work in the field of liver and pancreatic surgery––especially for pioneering many laparoscopic, robotic and ablative therapies for these cancers. He has assisted in the design and deployment of many novel surgical tools.

Dr. Fong has also been active in biologic bench investigation.  His early research was in immune activation during cancer or infection.  He was part of the group that discovered tumor necrosis factor and helped established the field of innate immunity. His laboratory focus over the last 15 years has been in the field of gene therapy, designing and studying the use of genetically modified viruses for the killing of cancer. His group was the first to administer recombinant viruses into the blood stream of man as a cancer treatment. His leadership in this field on the national level has included serving as the Chair of the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health.

He has co-authored over 700 peer reviewed articles and 12 text books. He has served on the editorial boards of 14 journals, and is currently Editor-in-Chief of Molecular Therapy Oncolytics (Cell Press).

Thursday, March 31, 2022 - 1300 - 1330hrs

Thursday, March 31, 2022 - 1300 - 1330hrs

Yuman Fong MD; USA
KN01 - Palliative Liver Resection
 
KN01 - Y Fong - Photo.jpg
Yuman Fong MD

Dr. Yuman Fong is a graduate of Brown University (BA, Medieval Literature, 1981) and Cornell University Medical College (MD, 1984). He is the Sangiacomo Chair and Chairman of the Department of Surgery at the City of Hope Medical Center.

Dr. Fong is best known clinically for his extensive work in the field of liver and pancreatic surgery––especially for pioneering many laparoscopic, robotic and ablative therapies for these cancers. He has assisted in the design and deployment of many novel surgical tools.

Dr. Fong has also been active in biologic bench investigation.  His early research was in immune activation during cancer or infection.  He was part of the group that discovered tumor necrosis factor and helped established the field of innate immunity. His laboratory focus over the last 15 years has been in the field of gene therapy, designing and studying the use of genetically modified viruses for the killing of cancer. His group was the first to administer recombinant viruses into the blood stream of man as a cancer treatment. His leadership in this field on the national level has included serving as the Chair of the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health.

He has co-authored over 700 peer reviewed articles and 12 text books. He has served on the editorial boards of 14 journals, and is currently Editor-in-Chief of Molecular Therapy Oncolytics (Cell Press).

Julie Heimbach MD; USA
KN02 - Contemporary Management of Hilar Cholangiocarcinoma
KN02 - J Heimbach - Photo.jpg
Julie Heimbach MD

Julie Heimbach is a Professor of Surgery and the Chair of Division of Transplantation at the Mayo Clinic College of Medicine in Rochester, MN.  She has dedicated a significant amount of time to UNOS, having served on numerous committees as well as the Board of Directors, and most recently, as the chair of the liver-Intestine committee.   Dr. Heimbach also recently served on the ASTS council and currently serves as an Associate Editor both for the American Journal of Transplantation, and for the Journal of Hepatology.  Her clinical and research interests include liver transplantation for hepatobiliary malignancies, living donor transplantation, and obesity in liver transplantation.

Andrea Schlegel MD; Italy/Switzerland
KN03 - An Ideal Liver Graft
Machine Perfusion
IHPBA_2022_Logo_72dpi.png
Andrea Schlegel MD

Dr. Yuman Fong is a graduate of Brown University (BA, Medieval Literature, 1981) and Cornell University Medical College (MD, 1984). He is the Sangiacomo Chair and Chairman of the Department of Surgery at the City of Hope Medical Center.

Dr. Fong is best known clinically for his extensive work in the field of liver and pancreatic surgery––especially for pioneering many laparoscopic, robotic and ablative therapies for these cancers. He has assisted in the design and deployment of many novel surgical tools.

Dr. Fong has also been active in biologic bench investigation.  His early research was in immune activation during cancer or infection.  He was part of the group that discovered tumor necrosis factor and helped established the field of innate immunity. His laboratory focus over the last 15 years has been in the field of gene therapy, designing and studying the use of genetically modified viruses for the killing of cancer. His group was the first to administer recombinant viruses into the blood stream of man as a cancer treatment. His leadership in this field on the national level has included serving as the Chair of the Recombinant DNA Advisory Committee (RAC) of the National Institutes of Health.

He has co-authored over 700 peer reviewed articles and 12 text books. He has served on the editorial boards of 14 journals, and is currently Editor-in-Chief of Molecular Therapy Oncolytics (Cell Press).

Thursday, March 31, 2022 - 1300 - 1330hrs

Friday, April 1, 2022

14:00 - 15:00
Vikram Chaudhari MD; India
Appleby




Free Papers 11: Pancreas 4
Vikram Chaudhari - Photo.JPG
Vikram Chaudhari MD

Dr. Vikram Chaudhari was appointed as a full time faculty in the GI and HPB Surgical Oncology division at the Tata Memorial Centre, Mumbai in 2016 and was promoted to the position of Professor in 2021. He is a recognized teacher and examiner for Mch Surgical Oncology in India.

GI and HPB Cancer surgery service at TMH is one of the busiest surgical units in the country. Dr. Chaudhari’s clinical and research focus has been Pancreatic tumors. He is an expert robotic and laparoscopic GI Oncosurgeon.  He has a special interest in managing Neuroendocrine Tumors and runs a specialty GEPNET clinic at TMH.

He is an active member of many national and international surgical organizations. He is currently an executive committee member of Indian chapter of International HPB Association.

He has published more than 40 peer reviewed indexed journal papers and has authored more than 15 book chapters. He has delivered more than 40 invited lectures and has performed 7 live operative demonstrations in various national and international meetings.

14:00 - 15:00
Xiangcheng Li MD; China
Combined Left Hemihepatectomy with PV Reconstruction and IVC Replacement for ICC in the Caudate Lobe of the Liver


Free Papers 12: Liver 3
Xiangcheng Li - Photo.jpg
Xiangcheng Li MD

Dr. Xiangcheng Li has a highly specialized practice focused on (1) Hepatobiliary malignancy, particularly patients with hepatocellular carcinoma and hilar cholangiocarcinoma, and (2) Liver transplantation, which involves living donor liver transplantation. Dr. Li is the vice director of Hepatobiliary Center, as well as professor of surgery at Nanjing Medical University. His particular area of clinical expertise is in the radical resection of advanced hilar cholangiocarcinoma and liver transplantation. He and his team performed the first living doner liver transplantation in the mainland of China. He was awarded the Best surgical video in 2012 Conference of International Hepato-Pancreato-Biliary Association.

Dr. Li is currently the Chairman of Oncology Society of Jiangsu province Medical Association and member of Biliary Tract Surgery Committee of Chinese Medical Association. He is also the member of the Membership and Communications Committee of Liver Transplantation Society (ILTS) as well as member of International Hepato-Pancreato-Biliary Association. Dr. Li runs many highly productive research programs focused on liver ischemia-reperfusion injury in liver transplantation, genomic characteristics of cholangiocarcinoma, and prognosis model of hepatobiliary malignancies, and has authored over 50 publications including Annals of Surgery, Annals of surgical oncology, J Immunother Cancer, Radiology, Journal of Hepatology, etc.

14:00 - 15:00
Rodrigo Sanchez Claria MD; Argentina
Laparoscopic Left Lateral Donor Hepatectomy for Pediatric Liver Transplantation


Free Papers 13: Transplant 3
Rodrigo Sanchez Claria - Photo.jpg
Rodrigo Sanchez Claria MD

Rodrigo Sanchez Claria. MD, FACS

Staff surgeon in HPB at Hospital Italiano de Buenos Aires

Director of intestinal and multiviceral transplant, Hospital Italiano de Buenos Aires

15:30 - 16:15
Claudius Conrad MD, PhD; USA
Anatomic Percystectomy for Hydatid Cyst Necessitating Extended Left Hepatectomy - Laparoscopic Optimization of the Parenchymal Transection Plane
Free Papers 15: Liver 4
Claudius Conrad - Photo.jpg
Claudius Conrad MD

Dr. Conrad is the chief of general surgery and surgical oncology at Saint Elizabeth Medical Center, associate professor of Tufts University School of Medicine, director of the Boston Liver, Pancreas, and Biliary Center and program director of the minimally invasive hepato-pancreato-biliary (HPB) surgery fellowship.


Dr. Conrad received two post-doctoral degrees, (stem cell biology and music philosophy) from University of Munich, and subsequently completed general surgery training at the Massachusetts General Hospital, where he became Instructor in Surgery at Harvard Medical School in 2011 as well as affiliated faculty at the Harvard Stem Cell Institute. Dr. Conrad also served as the Director of Music in Medicine at the Massachusetts General Hospital during this time and is recognized internationally as an expert on the role of music in medicine. He then received subspecialty training in surgical oncology at the Dana-Farber Surgical Oncology Program, followed in 2013 by the IHPBA Minimal Access Fellowship at the Institut Mutualist Montsouris in Paris and the University of Tokyo. Between 2013 and 2018, Dr. Conrad was an Assistant Professor at MD Anderson Cancer Center in Houston, TX.

 

Dr. Conrad’s current research focuses on novel techniques/technologies to treat complex liver and pancreas cancer. In this context, together with Prof. Gayet, he authored the first textbook and video atlas of laparoscopic HPB surgery. He currently serves as the program chair of the International Society of Laparoscopic Liver Surgery, and HPB committee member of the Society of Surgical Oncology, Society of Surgery of the Alimentary Tract and Society of American Gastrointestinal Surgeons. He has authored and coauthored some of the most impactful manuscripts in this field.

16:15 - 17:05
Nicolás Jarufe MD; Chile
Fully Laparoscopic Management of Mirizzi Syndrome with Bile Duct Reconstruction



Free Papers 16: Biliary 3
Nicolas Jarufe - Photo.png
Nicolás Jarufe MD

Professor of Surgery

HPB and Transplant Surgeon

Clinica Las Condes

Santiago-Chile